Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 August 2023 | Story Anthony Mthembu | Photo Supplied
Ndumiso Mbuthuma
Ndumiso Mbuthuma is currently pursuing a PhD in Development Studies with a focus on floods and disasters.

Ndumiso Mbuthuma, a PhD student at the University of the Free State (UFS), was part of a team that won the Durban leg of the Students Reinventing Cities competition. “It was a beautiful experience and an opportunity to not only be a student again but to contribute to the greater good,” Mbuthuma said.

The Students Reinventing Cities competition is coordinated by C40, a global network of nearly 100 mayors of the world’s leading cities who are united in action to confront the climate crisis.

The Umgeni Interchange Team, which consisted of Mbuthuma, who is a student in the UFS Centre for Development Support, three students from the University of Cape Town, and one from an institution in France, participated in the Durban leg of the competition, which began in April 2023. 

After deliberations by C40 and city representatives, the team was informed on 13 July 2023 that they had been selected as the winners of the regional Durban competition.

The Students Reinventing Cities competition provides a platform for students and academics to work with cities around the world to formulate plans to combat climate change. This year the competition took place in 12 cities, including Barcelona, Durban, Rome, Melbourne, and Milan, among others. “The aim of the competition is to find ways in which we can begin to build cities that are climate change-friendly,” Mbuthuma said. 

The winning presentation

The Umgeni Interchange Team was allocated four hectares of land by the eThekwini municipality to come up with a development idea. The team members, who specialise in various fields, had to rely on each other to create a winning project. Their proposal entailed the development of a mixed-use, commercial, retail, and affordable-housing block. 

“We wanted to ensure affordable housing not just for the rich but even for those who aren’t,” Mbuthuma explained. His PhD, which focuses on floods and disasters, provided guidance on ensuring that the housing block was resistant to floods and other disasters. The proposal also suggested sustainable resource use, including the use of solar panels to generate energy in order to reduce the impact of loadshedding. 

Even though a victory in the competition is a great feeling, Mbuthuma is more appreciative of the opportunity to have been active in the battle for a more sustainable future. “To hear that policymakers are interested in hearing what I have to say is a big deal to me.”

Future endeavours

Although there has been a concerted effort globally to combat climate change, Mbuthuma believes that in countries such as South Africa there hasn’t been adequate discourse around how development will take place in a future defined by climate change and the resulting disasters expected. As such, he is committed to working towards normalising these conversations.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept